These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 2826686)

  • 41. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
    Javitt DC; Frusciante MJ; Zukin SR
    Mol Pharmacol; 1990 May; 37(5):603-7. PubMed ID: 2160056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites.
    Rao TS; Contreras PC; Cler JA; Mick SJ; Dilworth VM; Iyengar S; Monahan JB; Wood PL
    J Neurochem; 1991 Mar; 56(3):890-7. PubMed ID: 1847186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and receptor binding studies of (+/-)1-iodo-MK-801.
    Yang DJ; Ciliax BJ; Van Dort ME; Gildersleeve D; Pirat JL; Young AB; Wieland DM
    Pharm Res; 1989 Jun; 6(6):474-6. PubMed ID: 2548173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication.
    Kloog Y; Nadler V; Sokolovsky M
    FEBS Lett; 1988 Mar; 230(1-2):167-70. PubMed ID: 2895019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex.
    Hubbard CM; Redpath GT; Macdonald TL; VandenBerg SR
    Brain Res; 1989 May; 486(1):170-4. PubMed ID: 2541870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of a high-affinity glutamate-controlled TCP binding site in rat brain postsynaptic densities.
    Foucaud B; Gombos G
    Eur J Pharmacol; 1990 Dec; 189(6):355-62. PubMed ID: 1981559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain.
    Silverstein FS; McDonald JW; Bommarito M; Johnston MV
    Stroke; 1990 Feb; 21(2):310-5. PubMed ID: 1968295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of Mg(2+)-dependent [3H]TCP binding by L-glutamate, glycine, and guanine nucleotides in rat cerebral cortex.
    Hori T; Yamamoto T; Hatta K; Moroji T
    Synapse; 1991 May; 8(1):13-21. PubMed ID: 1678554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The N-methyl-D-aspartate (NMDA) receptor complex: a stoichiometric analysis of radioligand binding domains.
    Thedinga KH; Benedict MS; Fagg GE
    Neurosci Lett; 1989 Sep; 104(1-2):217-22. PubMed ID: 2573014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [3H]PCP-3-OH and (+)[3H]SKF 10047 binding sites in rat brain membranes: evidence of multiplicity.
    Itzhak Y
    Eur J Pharmacol; 1987 Apr; 136(2):231-4. PubMed ID: 3036548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
    Ambar I; Kloog Y; Sokolovsky M
    J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.
    Javitt DC; Zukin SR
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):740-4. PubMed ID: 2536176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effects of N-methyl-D-aspartate agonists and antagonists.
    Itzhak Y
    Neurosci Lett; 1989 Oct; 104(3):314-9. PubMed ID: 2573019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel.
    Kloog Y; Haring R; Sokolovsky M
    Biochemistry; 1988 Feb; 27(3):843-8. PubMed ID: 2835078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity.
    Bresink I; Danysz W; Parsons CG; Mutschler E
    Neuropharmacology; 1995 May; 34(5):533-40. PubMed ID: 7566488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.